REQUEST A DEMO
Total
USD $0.00
Search more companies

Inner Mongolia Furui Medical Science Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Inner Mongolia Furui Medical Science Co., Ltd. Profile Updated: April 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Inner Mongolia Free Han & Mongolian Pharmaceutical Co.,Ltd. (FuRui) was founded in 1998. FuRui dedicates tohepatology, and focuses on liver fibrosis specially to buildup professional healthcare service system.After a decade of efforts, FuRui has become a modernpharmaceutical enterprise integrated with R & D, production,marketing and sales, and healthcare services. Fufang BiejiaRuangan Pian as the key product by treating liver fibrosishas been occupying the market share in the first positionfrom 1999. For the great achievements of FuRui, governmentassigned FuRui several honors and awards, such as Top 10Excellent Enterprise, the Best Tax Payment Enterprise andClass A Credit Taxpayers.With the high-tech and unique leading vision, FuRuicreates several brands in market and builds professionaland specific manufacturing in an industrial scale. Thepatent product Fufang Biejia Ruangan Pian received severalawards from government, which they are respectively, the3rd Prize Project of the National Sci-Tech Advance Awardin 1999, Hi-Tech Innovation by Inner Mongolia in 2001, andProduct in the list of TCM Protection by SFDA in 2003.Being the first pharmaceutical company to authorize GMPenterprise in October 2000, FuRui was also assigned as thehi-tech enterprise in 2002 and certified as the researchcenter in 2008 by government. By over 200 infrastructuresin manufacture site, the manufacturing capacity reachesthe advanced level with simultaneous production of over50 products in three dosage forms tablet, capsule andplaster.

Headquarters
7th Floor, Block 2, Kunsha Center, No. 16 Xinyuanli, Chaoyang District, Beijing
Chaoyang; Liaoning; Postal Code: 100027

Contact Details: Purchase the Inner Mongolia Furui Medical Science Co., Ltd. report to view the information.

Website: http://www.fu-rui.com

Basic Information
Total Employees:
Purchase the Inner Mongolia Furui Medical Science Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Inner Mongolia Furui Medical Science Co., Ltd. report to view the information.
Registered Capital:
Purchase the Inner Mongolia Furui Medical Science Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Inner Mongolia Furui Medical Science Co., Ltd. report to view the information.
Incorporation Date:
November 26, 1998
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
11.31%
Purchase this report to view the information.
6.04%
Purchase this report to view the information.
3.54%
Purchase this report to view the information.
2.96%
Purchase this report to view the information.
2.77%
Subsidiaries
Beijing Aigan Lifelong Health Management Co., Ltd.
Beijing Free Cloud Health Management Co., Ltd.
Beijing Furui Medical Cloud Health Management Co., Ltd.
Company Performance
Financial values in the chart are available after Inner Mongolia Furui Medical Science Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
33.35%
Total operating revenue
33.04%
Operating profit (EBIT)
32.44%
EBITDA
14.35%
Net Profit (Loss) for the Period
81.29%
Total assets
3.11%
Total equity
-1.01%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
5.36%
Return on Equity (ROE)
1.61%
Debt to Equity Ratio
-0.06%
Quick Ratio
-0.56%
Cash Ratio
-0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?